| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8d2afa63dbd8bbb90545722d3f54c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9d0c82c6254d5b4bec8c96e45c9db7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e41eefe437d41c6b293dbdc3abd7297f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dee4d0256899079a7834618d7051211 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2871 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2018-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_553090e48d87242ed38189859662231b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6d28bae04d2f2d5fdf06f6ec3a044b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88856dae99ff0a605cbe8f04726e7a44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f50fd0f1cc6e3b4e2d6d9e124147851a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4f918109821ccae668d23b51e55d062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6143dac39182d44ae8ca2bd42296b53d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1983c84156674894e65933d85561492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21f00768f6c37b75cdc0e40850640ae0 |
| publicationDate |
2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019107256-A1 |
| titleOfInvention |
Body fluid antibody biomarker for highly sensitive detection of risk of onset of cerebral infarction |
| abstract |
The present invention provides an acquisition method for data relating to the onset of a cerebral infarction, said method being characterized by measuring the antibody levels for DIDO1 protein or a portion thereof, and/or CPSF2 protein or a portion thereof, in a body fluid sample which has been isolated from a living body. Also provided is a data acquisition kit for performing said method. The present invention enables signs linked to the onset of a cerebral infarction to be accurately discerned. |
| priorityDate |
2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |